[S-48] Symposium 48
State-of-the-art basic research for Alzheimer's disease

[S-48-4] Genomic integrity in Alzheimer's disease

^○Tatsuo Mano (Department of Neurology, The University of Tokyo, Japan)

In recent years, many clinical trials for Alzheimer's disease (AD) have ended in disappointment. Now it's time to rethink strategy to defeat AD. In this symposium, researchers at the vanguard of AD basic research will introduce their recent remarkable work, including elucidation of AD pathomechanisms, generation of AD animal models, and establishing new concepts of therapies and biomarkers utilizing cutting-edge technologies. We believe that talk in this session will provide neurologists important insights to gain a better understanding of AD.

Education:
Mar 2016 Ph.D. (Neurology)
The University of Tokyo, Graduate School of Medicine
Mar 2007 M.D.
The University of Tokyo, Faculty of Medicine

Work Experience:
Jun 2018 to Present Research associate
Apr 2016 to Dec 2017 Project Research Associate
Apr 2012 to Mar 2013 Medical Staff in Yokohama Rosai Hospital
Oct 2010 to Mar 2011 Medical Staff in NTT Medical Center Tokyo
Apr 2009 to Mar 2010 Medical Staff in The University of Tokyo Hospital
Apr 2007 to Mar 2009 Junior Resident in The University of Tokyo Hospital

Award:
2016 Presentation Award from Japan Society for Dementia Research
2019 Research on Aging and Health Award